Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada.
Oral Pathology and Oral Medicine, Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada.
FASEB J. 2023 Aug;37(8):e23097. doi: 10.1096/fj.202300672R.
Colorectal cancer (CRC) is a high prevalence adenocarcinoma with progressive increases in metastasis-related mortality, but the mechanisms governing the extracellular matrix (ECM) degradation important for metastasis in CRC are not well-defined. We investigated a functional relationship between vimentin (Vim) and myosin 10 (Myo10), and whether this relationship is associated with cancer progression. We tested the hypothesis that Vim regulates the aggregation of Myo10 at the tips of cell extensions, which increases membrane-type 1 matrix metalloproteinase (MT1-MMP)-associated local collagen proteolysis and ECM degradation. Analysis of CRC samples revealed colocalization of Vim with Myo10 and MT1-MMP in cell extensions adjacent to sites of collagen degradation, suggesting an association with local cell invasion. We analyzed cultured CRC cells and fibroblasts and found that Vim accelerates aggregation of Myo10 at cell tips, which increases the cell extension rate. Vim stabilizes the interaction of Myo10 with MT1-MMP, which in turn increases collagenolysis. Vim depletion reduced the aggregation of Myo10 at the cell extension tips and MT1-MMP-dependent collagenolysis. We propose that Vim interacts with Myo10, which in turn associates with MT1-MMP to facilitate the transport of these molecules to the termini of cell extensions and there enhance cancer invasion of soft connective tissues.
结直肠癌(CRC)是一种高发性腺癌,其转移相关死亡率呈渐进式上升,但调控结直肠癌转移中细胞外基质(ECM)降解的机制尚未明确。本研究旨在探究波形蛋白(Vim)与肌球蛋白 10(Myo10)之间的功能关系,以及这种关系是否与癌症进展有关。研究假设 Vim 可调控 Myo10 在细胞延伸末端的聚集,从而增加膜型基质金属蛋白酶 1(MT1-MMP)相关局部胶原蛋白水解和 ECM 降解。CRC 样本分析显示,Vim 与 Myo10 和 MT1-MMP 在胶原降解部位附近的细胞延伸处共定位,提示其与局部细胞侵袭有关。本研究还分析了培养的 CRC 细胞和成纤维细胞,发现 Vim 可加速 Myo10 在细胞尖端的聚集,从而提高细胞延伸率。Vim 稳定了 Myo10 与 MT1-MMP 的相互作用,进而增加了胶原水解。Vim 耗竭则减少了细胞延伸尖端的 Myo10 聚集以及 MT1-MMP 依赖性胶原水解。综上,Vim 与 Myo10 相互作用,进而与 MT1-MMP 结合,促进这些分子向细胞延伸末端的转运,从而增强癌症对软结缔组织的侵袭。